David J. Chaplin - Concepedia

Author

David J. Chaplin

Also Known As

Chaplin, D.J., Chaplin, David J., D J Chaplin, D. Chaplin, D. J. Chaplin, D.J Chaplin, D.J. CHAPLIN, D.J. Chaplin, DJ Chaplin, David Chaplin

215

Publications

9.7K

Citations

H-Index

Concepts

All Affiliations

Mount Vernon Hospital Baylor University Occupational Cancer Research Centre National Cancer Institute Danish Cancer Society

About

David J. Chaplin is an author at Mount Vernon Hospital specializing in medicine, pharmacology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	40	77	6K
2	Health Sciences	15	16	1.5K
3	Natural Sciences	10	10	481
4	Engineering	7	7	636
5	Allergy	1	1	15

David J. Chaplin

109

Publications

8.1K

Citations

H-Index

Page 1

	Year	Citations
Therapy-Induced Acute Recruitment of Circulating Endothelial Progenitor Cells to Tumors Yuval Shaked, Alessia Ciarrocchi, Marcela Franco, Science Cell TherapyViable Tumor RimImmunologyBiological MicroenvironmentsTumor Biology	2006	567
Intermittent blood flow in a murine tumor: radiobiological effects. David J. Chaplin, Peggy L. Olive, Ralph E. Durand PubMed Oncologic ImagingIntermittent Blood FlowMetronomic ChemotherapyTumor BiologyBlood Flow	1987	438
Combretastatin A-4 phosphate as a tumor vascular-targeting agent: early effects in tumors and normal tissues. G. M. Tozer, Vivien E. Prise, John Wilson, PubMed Quantitative AutoradiographyPathologyTumor BiologyBlood FlowAngiogenesis	1999	324
Phase I Trial of the Antivascular Agent Combretastatin A4 Phosphate on a 5-Day Schedule to Patients With Cancer: Magnetic Resonance Imaging Evidence for Altered Tumor Blood Flow James Stevenson, Mark Rosen, Weijing Sun, Journal of Clinical Oncology	2003	292
Mechanisms associated with tumor vascular shut-down induced by combretastatin A-4 phosphate: intravital microscopy and measurement of vascular permeability. Gillian M. Tozer, Vivien E. Prise, John Wilson, PubMed PharmacotherapyBiomedical EngineeringTumor BiologyVascular PermeabilityAngiogenesis	2001	288
Acute hypoxia in tumors: Implications for modifiers of radiation effects David J. Chaplin, R. E. Durand, Peggy L. Olive International Journal of Radiation OncologyBiologyPhysics Radiation TherapyMedicineRadiation EffectRadiation ExposureAcute Hypoxia	1986	266
Anti-vascular approaches to solid tumour therapy: evaluation of combretastatin A4 phosphate. David J. Chaplin, George R. Pettit, S A Hill PubMed PathologyBiomedical EngineeringMetronomic ChemotherapyTumor BiologyBlood Flow	1999	252
ZD6126: a novel vascular-targeting agent that causes selective destruction of tumor vasculature. Peter D. Davis, Graeme J. Dougherty, David C. Blakey, Oxford University Research Archive (ORA) (University of Oxford) Endothelial Cell MorphologyChemoprevention StrategyTumor BiologyNovel Vascular-targeting AgentAngiogenesis	2002	231
The use of fluorescent probes to identify regions of transient perfusion in murine tumors Martin J. Trotter, David J. Chaplin, Ralph E. Durand, International Journal of Radiation OncologyBiologyPhysics Transient PerfusionTissue ImagingEngineeringOncologic ImagingBiomedical Imaging	1989	171
Vinca alkaloids: Anti-vascular effects in a murine tumour Stephen Hill, Sarah Lonergan, J. Denekamp, European Journal of Cancer Vinca AlkaloidsMedicinePharmacologyPharmacotherapyAnti-cancer Agent	1993	167

Page 1